The present invention is directed toward a humanized neutralizing monoclonal antibody to hepatocyte growth factor, a pharmaceutical composition comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient.

 
Web www.patentalert.com

< Antibodies that bind human 17-A1/EpCAM tumor antigen

> Radioimmunoconjugates for targeted alpha therapy

> Cyclosporin alkynes and their utility as pharmaceutical agents
~ 00566